I guess what I am saying is that we have not had c
Post# of 36536
We had communications that they were getting funding for things, but then silence after. We had communication in a 10Q on Excellegan, Arizona, Florida, Ohio and some deals pertaining to those initiatives, then nothing.
Some of these go back a ways. Arizona was known months and months ago.
The lack of communication recently would lead to expectations of no communication ongoing as well until FDA approval or lack of. It's getting to the point you don't know what to expect from Generex / NGIO. The inconsistency in the way they do communicate is simply amazing and what they communicate or lack thereof is the issue.
They have a lot of things going on. I will give them that and I think with that, it lends to a lot of frustration on the part of shareholders because we all want to know what is going on with everything. We all want results after so long and seeing everyone else coming out with vaccines, seeing other companies succeeding, seeing the PRs, being on the conference calls and then seeing the PPS keep going down.
I also sent Todd an email expressing my concerns as a shareholder. Professional as I could
With all this though, I am still holding my shares because I am still believing things are right around the corner, even as the PPS slowly dips further down.